Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

Sclerostin Quo Vadis? - Is This a Useful Long-Term Mortality Parameter in Prevalent Hemodialysis Patients?

Background/Aims: Cardiovascular calcification contributes to the increased mortality in hemodialysis patients. Sclerostin was identified as an antianabolic bone factor causing soft tissue calcification. Data on prospective large-scale studies associating sclerostin with mortality in hemodialysis pat...

Full description

Bibliographic Details
Main Authors: Albina Nowak, Ferruh Artunc, Andreas L. Serra, Emily Pollock, Pierre-Alexandre Krayenbühl, Christian Müller, Björn Friedrich
Format: Article
Language:English
Published: Karger Publishers 2015-05-01
Series:Kidney & Blood Pressure Research
Subjects:
Sclerostin
Cardiovascular
Hemodialysis
Mortality
Online Access:http://www.karger.com/Article/FullText/368502

Internet

http://www.karger.com/Article/FullText/368502

Similar Items